A promising noninvasive method is receptor scintigraphy with radiolabeled glucagon-like peptide 1 (GLP-1) receptor analogs, which is shown to be highly sensitive for insulinoma tissue [6,9]. The gene discussed is GLP1R; the disease is pancreatic insulinoma.